Selegiline effects on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus

Biogenic Amines

Volumn 16, Issue 6, 2001, Pages 523-530

  Hamaue, N ^a   Ogata, A ^a   Terado, M ^a   Endo, T ^a   Makiura, T ^a   Hirafuji, M ^a   Yasui, K ^a   Nagashima, K ^a   Tashiro, K ^a   Minami, M ^a   Parvez, S H ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Dopamine; Japanese encephalitis virus; Monoamine oxidase inhibitor; Parkinson's disease; Selegiline

Indexed keywords

ALUMINUM OXIDE; CATECHOLAMINE; CHLORALOSE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; EDETIC ACID; MONOAMINE OXIDASE B INHIBITOR; NITROGEN; PERCHLORIC ACID; SELEGILINE; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYKINESIA; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; DRUG EFFECT; JAPANESE ENCEPHALITIS VIRUS; MOTOR ACTIVITY; NONHUMAN; PARKINSON DISEASE; RAT; VIRUS INFECTION;

EID: 0035571007     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Possible mechanisms of action of (-) deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders
2. Conservation of hippocampal memory function in rats and humans
3. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
4. Verteilung von noradrenaline und dopamine (3-hydroxytyramin) im Gehirn des Menschen und ihr verhalten bei erkrankungen des extrapyramidalen Systems
5. Infection of the basal ganglia by a murine coronavirus
6. Pharmacology of selegiline
7. Dopamine is a monoamine oxidase B substrate in man
8. 3H]dopa in various regions of the brain
9. Monoamine oxidase in sympathetic nerves: A transmitter specific enzyme type
10. Identification of isatin, an endogenous MAO inhibitor, in the brain of stroke-prone SHR
11. Endogenous monoamine oxidase (MAO) inhibitor (tribulin-like activity) in the brain and urine of stroke-prone SHR
12. Urinary isatin concentrations in patients with Parkinson's disease determined by a newly developed HPLC-ECD method
13. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,4,6-tetrahydropyridine in mice
14. Some observations upon a new inhibitor of monoamine oxidase in brain tissues
15. The possible mechanisms of action of (-) deprynyl in Parkinson's disease
16. Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer
17. Some puzzling effects of monoamine oxidase inhibitors
18. Chornic parkinsonism in humans due to a product of meperidine-analog synthesis
19. Measurement with the folin phenol reagent
20. MAO in hypertension
21. Japanese encephalitis virus neurotropism is dependent on the degree of neuronal maturity
22. A rat model of Parkinson's disease induced by Japanese encephalitis virus
23. A simple quantitative bradykinesia test in MPTP-treated mice
24. The substantia nigra is a major target for neurovirulent influenza a virus
25. The nature and locations of the multiple forms of monoamine oxidase
26. Some statistical methods useful in circulation research
27. β-Phenylethylamine: A specific substrate for type B monoamine oxidase of brain